Cargando…

Understanding and addressing vaccine hesitancy in the context of COVID-19: development of a digital intervention

OBJECTIVES: Severe Acute Respiratory Coronavirus 2 (SARS-CoV-2) was identified in late 2019, spreading to over 200 countries and resulting in almost two million deaths worldwide. The emergence of safe and effective vaccines provides a route out of the pandemic, with vaccination uptake of 75–90% need...

Descripción completa

Detalles Bibliográficos
Autores principales: Knight, H., Jia, R., Ayling, K., Bradbury, K., Baker, K., Chalder, T., Morling, J.R., Durrant, L., Avery, T., Ball, J.K., Barker, C., Bennett, R., McKeever, T., Vedhara, K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society for Public Health. Published by Elsevier Ltd. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520885/
https://www.ncbi.nlm.nih.gov/pubmed/34801843
http://dx.doi.org/10.1016/j.puhe.2021.10.006
_version_ 1784584775990771712
author Knight, H.
Jia, R.
Ayling, K.
Bradbury, K.
Baker, K.
Chalder, T.
Morling, J.R.
Durrant, L.
Avery, T.
Ball, J.K.
Barker, C.
Bennett, R.
McKeever, T.
Vedhara, K.
author_facet Knight, H.
Jia, R.
Ayling, K.
Bradbury, K.
Baker, K.
Chalder, T.
Morling, J.R.
Durrant, L.
Avery, T.
Ball, J.K.
Barker, C.
Bennett, R.
McKeever, T.
Vedhara, K.
author_sort Knight, H.
collection PubMed
description OBJECTIVES: Severe Acute Respiratory Coronavirus 2 (SARS-CoV-2) was identified in late 2019, spreading to over 200 countries and resulting in almost two million deaths worldwide. The emergence of safe and effective vaccines provides a route out of the pandemic, with vaccination uptake of 75–90% needed to achieve population protection. Vaccine hesitancy is problematic for vaccine rollout; global reports suggest only 73% of the population may agree to being vaccinated. As a result, there is an urgent need to develop equitable and accessible interventions to address vaccine hesitancy at the population level. STUDY DESIGN: & Method: We report the development of a scalable digital intervention seeking to address COVID-19 vaccine hesitancy and enhance uptake of COVID-19 vaccines in the United Kingdom. Guided by motivational interviewing (MI) principles, the intervention includes a series of therapeutic dialogues addressing 10 key concerns of vaccine-hesitant individuals. Development of the intervention occurred linearly across four stages. During stage 1, we identified common reasons for COVID-19 vaccine hesitancy through analysis of existing survey data, a rapid systematic literature review, and public engagement workshops. Stage 2 comprised qualitative interviews with medical, immunological, and public health experts. Rapid content and thematic analysis of the data provided evidence-based responses to common vaccine concerns. Stage 3 involved the development of therapeutic dialogues through workshops with psychological and digital behaviour change experts. Dialogues were developed to address concerns using MI principles, including embracing resistance and supporting self-efficacy. Finally, stage 4 involved digitisation of the dialogues and pilot testing with members of the public. DISCUSSION: The digital intervention provides an evidence-based approach to addressing vaccine hesitancy through MI principles. The dialogues are user-selected, allowing exploration of relevant issues associated with hesitancy in a non-judgmental context. The text-based content and digital format allow for rapid modification to changing information and scalability for wider dissemination.
format Online
Article
Text
id pubmed-8520885
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher The Royal Society for Public Health. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-85208852021-10-18 Understanding and addressing vaccine hesitancy in the context of COVID-19: development of a digital intervention Knight, H. Jia, R. Ayling, K. Bradbury, K. Baker, K. Chalder, T. Morling, J.R. Durrant, L. Avery, T. Ball, J.K. Barker, C. Bennett, R. McKeever, T. Vedhara, K. Public Health Original Research OBJECTIVES: Severe Acute Respiratory Coronavirus 2 (SARS-CoV-2) was identified in late 2019, spreading to over 200 countries and resulting in almost two million deaths worldwide. The emergence of safe and effective vaccines provides a route out of the pandemic, with vaccination uptake of 75–90% needed to achieve population protection. Vaccine hesitancy is problematic for vaccine rollout; global reports suggest only 73% of the population may agree to being vaccinated. As a result, there is an urgent need to develop equitable and accessible interventions to address vaccine hesitancy at the population level. STUDY DESIGN: & Method: We report the development of a scalable digital intervention seeking to address COVID-19 vaccine hesitancy and enhance uptake of COVID-19 vaccines in the United Kingdom. Guided by motivational interviewing (MI) principles, the intervention includes a series of therapeutic dialogues addressing 10 key concerns of vaccine-hesitant individuals. Development of the intervention occurred linearly across four stages. During stage 1, we identified common reasons for COVID-19 vaccine hesitancy through analysis of existing survey data, a rapid systematic literature review, and public engagement workshops. Stage 2 comprised qualitative interviews with medical, immunological, and public health experts. Rapid content and thematic analysis of the data provided evidence-based responses to common vaccine concerns. Stage 3 involved the development of therapeutic dialogues through workshops with psychological and digital behaviour change experts. Dialogues were developed to address concerns using MI principles, including embracing resistance and supporting self-efficacy. Finally, stage 4 involved digitisation of the dialogues and pilot testing with members of the public. DISCUSSION: The digital intervention provides an evidence-based approach to addressing vaccine hesitancy through MI principles. The dialogues are user-selected, allowing exploration of relevant issues associated with hesitancy in a non-judgmental context. The text-based content and digital format allow for rapid modification to changing information and scalability for wider dissemination. The Royal Society for Public Health. Published by Elsevier Ltd. 2021-12 2021-10-18 /pmc/articles/PMC8520885/ /pubmed/34801843 http://dx.doi.org/10.1016/j.puhe.2021.10.006 Text en © 2021 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Original Research
Knight, H.
Jia, R.
Ayling, K.
Bradbury, K.
Baker, K.
Chalder, T.
Morling, J.R.
Durrant, L.
Avery, T.
Ball, J.K.
Barker, C.
Bennett, R.
McKeever, T.
Vedhara, K.
Understanding and addressing vaccine hesitancy in the context of COVID-19: development of a digital intervention
title Understanding and addressing vaccine hesitancy in the context of COVID-19: development of a digital intervention
title_full Understanding and addressing vaccine hesitancy in the context of COVID-19: development of a digital intervention
title_fullStr Understanding and addressing vaccine hesitancy in the context of COVID-19: development of a digital intervention
title_full_unstemmed Understanding and addressing vaccine hesitancy in the context of COVID-19: development of a digital intervention
title_short Understanding and addressing vaccine hesitancy in the context of COVID-19: development of a digital intervention
title_sort understanding and addressing vaccine hesitancy in the context of covid-19: development of a digital intervention
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520885/
https://www.ncbi.nlm.nih.gov/pubmed/34801843
http://dx.doi.org/10.1016/j.puhe.2021.10.006
work_keys_str_mv AT knighth understandingandaddressingvaccinehesitancyinthecontextofcovid19developmentofadigitalintervention
AT jiar understandingandaddressingvaccinehesitancyinthecontextofcovid19developmentofadigitalintervention
AT aylingk understandingandaddressingvaccinehesitancyinthecontextofcovid19developmentofadigitalintervention
AT bradburyk understandingandaddressingvaccinehesitancyinthecontextofcovid19developmentofadigitalintervention
AT bakerk understandingandaddressingvaccinehesitancyinthecontextofcovid19developmentofadigitalintervention
AT chaldert understandingandaddressingvaccinehesitancyinthecontextofcovid19developmentofadigitalintervention
AT morlingjr understandingandaddressingvaccinehesitancyinthecontextofcovid19developmentofadigitalintervention
AT durrantl understandingandaddressingvaccinehesitancyinthecontextofcovid19developmentofadigitalintervention
AT averyt understandingandaddressingvaccinehesitancyinthecontextofcovid19developmentofadigitalintervention
AT balljk understandingandaddressingvaccinehesitancyinthecontextofcovid19developmentofadigitalintervention
AT barkerc understandingandaddressingvaccinehesitancyinthecontextofcovid19developmentofadigitalintervention
AT bennettr understandingandaddressingvaccinehesitancyinthecontextofcovid19developmentofadigitalintervention
AT mckeevert understandingandaddressingvaccinehesitancyinthecontextofcovid19developmentofadigitalintervention
AT vedharak understandingandaddressingvaccinehesitancyinthecontextofcovid19developmentofadigitalintervention